-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Editorial: Tiotropium; more knowledge leads to more questions ||FREE PAPER||
(2273) Views (478) Full article downloads
Authors: Dave Singh
Published Date March 2008
Volume 2008:3(1) Pages 0 - 0
DOI: http://dx.doi.org/10.2147/COPD.S
Dave Singh
Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, University of Manchester, Southmoor Rd, M23 9QZ, UK
This issue of the International Journal of COPD has 3 original research papers that study the effects of tiotropium. These papers are very different, addressing the effect of tiotropium on the small airways (Incorvaia et al 2008), the benefit of additional tiotropium treatment during a pulmonary rehabilitation programme (Kesten et al 2008), and the effect of tiotropium when prescribed to patients already taking theophylline (Kawayama et al 2008). Each paper offers new information about the effects of tiotropium, but also leads us towards further questions that need answering.
Readers of this article also read:
Patient education programs – can they improve outcomes in COPD?
Focusing on outcomes: Making the most of COPD interventions
A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD
Tiotropium HandiHaler® in the treatment of COPD: A safety review
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




